Tulane study finds potential treatment for eosinophilic esophagitis

FHS
July 31, 2023
12:17 pm

A new study from Tulane University has identified a new treatment for a chronic immune system disease that can prevent children from eating.

Pfizer partners with Flagship genetics startup Quotient on heart and kidney drugs

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 29, 2024

Anvatabart opadotin by Ambrx Biopharma for Gastric Cancer: Likelihood of Approval

Anvatabart opadotin is under clinical development by Ambrx Biopharma and currently in Phase I for Gastric Cancer.

February 9, 2024

EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer

Following the FDA’s lead, the European Medicines Agency will require labeling for CAR T-cell therapies to include a notice about a risk of second malignancies

June 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.